Contextualizing clinical trials with real-world data
As real-world data (RWD) continues to be increasingly used by the pharmaceutical industry and...
As real-world data (RWD) continues to be increasingly used by the pharmaceutical industry and...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
The use of real-world data has been gaining traction in the healthcare and life sciences...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that gradually erodes memory and cognitive function, affecting patients and their families long before the disease reaches its final stages.¹ As the population...